Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

BESPOKE CRC: observational study of tumor-informed ctDNA after colorectal resection

Observational study of serial tumor-informed ctDNA after surgery for stage I to IV colorectal cancer, with clinician-directed therapy. ClinicalTrials.gov lists the status as unknown.

Natera, Inc.